FemRx
This article was originally published in The Gray Sheet
Executive Summary
Receives NASDAQ notification that the maker of minimally invasive surgical systems "fails to meet certain requirements for continued listing," the firm states. Net tangible assets of $3.5 mil. fall below the $4 mil. mark required by NASDAQ. An appeal has been filed and the firm's stock will remain on the NASDAQ national market for now